Abbott Laboratories’s recently made public that its EXECUTIVE VICE PRESIDENT ALLEN HUBERT L unloaded Company’s shares for reported $16.86 million on Jan 29 ’25. In the deal valued at $128.35 per share,131,360 shares were sold. As a result of this transaction, ALLEN HUBERT L now holds 184,806 shares worth roughly $23.64 million.
Then, ALLEN HUBERT L sold 58,428 shares, generating $7,482,629 in total proceeds. Upon selling the shares at $128.07, the EXECUTIVE VICE PRESIDENT now owns 184,806 shares.
Before that, Salvadori Daniel Gesua Sive sold 23,771 shares. Abbott Laboratories shares valued at $3,054,574 were divested by the EXECUTIVE VICE PRESIDENT at a price of $128.50 per share. As a result of the transaction, Salvadori Daniel Gesua Sive now holds 125,697 shares, worth roughly $16.08 million.
Oppenheimer initiated its Abbott Laboratories [ABT] rating to an Outperform in a research note published on October 08, 2024; the price target was $130. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Edward Jones also remained covering ABT and has decreased its forecast on July 30, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on May 30, 2024. It rated ABT as “a Buy”.
Price Performance Review of ABT
On Friday, Abbott Laboratories [NYSE:ABT] saw its stock fall -0.68% to $127.93. Over the last five days, the stock has gained 2.32%. Abbott Laboratories shares have risen nearly 13.10% since the year began. Nevertheless, the stocks have risen 12.73% over the past one year. While a 52-week high of $129.85 was reached on 01/28/25, a 52-week low of $99.71 was recorded on 01/15/25. SMA at 50 days reached $116.60, while 200 days put it at $111.22.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 127.49, which if violated will result in even more drops to 127.04. On the upside, there is a resistance level at 128.57. A further resistance level may holdings at 129.20. The Relative Strength Index (RSI) on the 14-day chart is 71.49, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.56, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 10.11%. Stochastics %K at 91.31% indicates the stock is a selling.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2024-12-31, growing by 0.75 million shares to a total of 14.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 13.57 million shares. There was a rise of 5.23%, which implies that there is a positive sentiment for the stock.
